DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202325

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anaemia during pregnancy

Alpesh R. Patel, Vipul S. Patel, Parth R. Patel

Abstract


Background: Iron deficiency anemia during pregnancy is a serious global concern specially in developing country, which is preventable with effective measures. In women who cannot tolerate oral iron or have moderate to severe anemia, parenteral iron in the form of iron sucrose or ferric carboxymaltose can be very much useful. This study aimed to compare efficacy and safety of iron sucrose and ferric carboxymaltose in iron deficiency anemia during pregnancy.

Methods: This prospective interventional comparative study was conducted during May 2016 to April 2018 at tertiary care hospital and total 100 antenatal women from 28 to 34 weeks of gestation having moderate to severe anemia were included in this study and all women were divided in to 2 groups randomly and were given either iron sucrose or ferric carboxymaltose according to iron requirement. Rise in haemoglobin and serum ferritin were noted and data analysed statistically.

Results: The mean rise of haemoglobin with iron sucrose was 1.8 gm% and with ferric carboxymaltose was 2.6 gm%. The mean rise of serum ferritin with iron sucrose was 82.4 ng/ml and with ferric carboxymaltose was 100.9 ng/ml. Other than minimal local reaction one woman had developed severe anaphylactic reaction after receiving iron sucrose.

Conclusions: Intravenous ferric carboxymaltose is better and safe molecule than iron sucrose and it has advantage of ability to administer large dose in single sitting which reduce overall cost of therapy.  Hence ferric carboxymaltose is a drug of choice as parenteral iron therapy in iron deficiency anemia during second trimester of pregnancy.

 


Keywords


Ferric carboxymaltose, Haemoglobin, Iron sucrose, Parenteral iron therapy

Full Text:

PDF

References


World health organization. micronutrient deficiency: prevention and control guidelines. Geneva, WHO; 2015. Available at: https://www.who.int/nutrition /topics/ida/en/. Accessed on 10th February 2020.

FOGSI general clinical practice recommendations. Management of iron deficiency anemia in pregnancy; 2016. Available at: https://www.fogsi.org/wp-content/uploads/2016/05/The-evidence-base_IDA-Pregnancy-24-May-2016-Clean.pdf. Accessed on 12th February 2020.

Sing P, Toteja GS. Micronutrient profile of Indian children and women: summary of available data for iron and vitamin A. Indian Paediatr. 2003;40(5):477-9.

Milnam N. Prepartum anemia” Prevention and treatment. Ann Haematol. 2008;87:949-59.

Indian Council of Medical Research. Evaluation of the national nutritional anemia prophylaxis programme. An ICMR Task Force Study. New Delhi ICMR; 1989.

Kriplani A, Reeta M, Nootan A. Intra venous iron sucrose therapy for moderate to severe anemia in pregnancy. Indian J Med Res. 2013;138:78-82.

Geisser P. The pharmacology and safety profile of ferric carboxymaltose (Ferinject®): structure/ reactivity relationships of iron preparations. Portug J Nephrol Hypert. 2009;23:11-6.

Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med. 2012;40(5):469-74.

Ambily J, Reeta M, Neerja B, Renu S, Mani K, Alka K. Comparison of ferric carboxy maltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomized controlled trial. BMC Preg Childbirth. 2019;19:54.

Agrawal D, Deepa L. A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2019;8(6):2280-5.

Shabina K, Shivika G. A comparative study of injection ferric carboxymaltose and iron sucrose in anaemia complicating pregnancy. Int J Contemp Med Res. 2019;6(8):H6-9.

Qassim A, Mol BW, Grivell RM, Grjeskoviak LE. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltosein pregnancy: A systematic review. Aust N Z J Obstet Gynaecol. 2018;58(1):22-39.